Pfizer Australia to relocate to a state of the art CBD location in 2018

Pfizer Australia to relocate to a state of the art CBD location in 2018
Joel RobinsonDecember 7, 2020

Pfizer Australia, one of the world's leading biopharmaceutical companies, is relocating its Australian office into a new building in the heart of the Sydney CBD.

The building - Barrack Place, at 151 Clarence St, will be one of the most advanced buildings in its class in Sydney when it is finished in 2018.

Pfizer will occupy the top four floors of this new prestigious building in an emerging entrepreneurial and innovation hub. The immediate business precinct is where many innovative businesses have set up such as Atlassian and Apple.

Melissa McGregor, managing director of Pfizer Australia said the company are proud of their manufacturing legacy at their West Ryde site over the past 60 years.

“Locating Pfizer Australia in this burgeoning business precinct - in the heart of the Sydney CBD - positions us strongly for the next 60 years. We are making a deliberate move to be at the cross section of society businesses, Government, customers, and the general community all intersect in the Sydney CBD.

We will be part of the innovation and creativity that surrounds the area. In part because of the location, we will continue to attract vibrant and talented people to work at Pfizer Australia, as we have done for many years.

Pfizer Australia to relocate to a state of the art CBD location in 2018

Pfizer is delivering on its sustainability responsibilities by getting 400 single- occupancy cars off the road every business day.

The building is currently under construction and is being built to world-class standards in terms of amenities, energy rating and environmental sustainability.

“As it’s a new building, we have the opportunity to design, shape and construct our internal workspace to our exacting and unique specifications. As you can appreciate, such opportunities are rare – particularly in this exciting location,” McGregor said.

Pfizer Australia plans to move its employees by December 2018 when building works are completed. Pfizer was assisted by Pepper Property for its Sydney office search.

Joel Robinson

Joel Robinson is a property journalist based in Sydney. Joel has been writing about the residential real estate market for the last five years, specializing in market trends and the economics and finance behind buying and selling real estate.

Editor's Picks